Miami Medical Center USA Inc is categorized under Hospitalization Plans in Miami, FL and active since 1993.
Miami Medical Center USA Inc was established in 1993, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitalization Plans business, which does work in the BOTH market, and is classified as a Hospitalization Plans, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Frank Recio, International at the company’s single location by writing to 2307 Douglas Road, Miami, Florida FL 33145 or by phoning (305) 446-0808. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Miami Medical Center USA Inc |
Contact Person: | Frank Recio, International |
Address: | 2307 Douglas Road, Miami, Florida 33145 |
Phone Number: | (305) 446-0808 |
Website Address: | mmcusa.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Hospitalization Plans |
SIC Code: | 6324 |
NAICS Code: | 6219993 |
Share This Business: |
Miami Medical Center USA Inc was started in 1993 to provide professional Hospitalization Plans under the SIC code 6324 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Frank Recio, International for inquiries that concern Miami Medical Center USA Inc by calling the company number (305) 446-0808, as your correspondence is most welcome. Additionally, the physical location of the single location of Miami Medical Center USA Inc can be found at the coordinates 25.74778,-80.25444 as well as the street address 2307 Douglas Road in Miami, Florida 33145.
For its online presence, you may visit Miami Medical Center USA Inc’s website at mmcusa.com and engage with its social media outlets through on Twitter and on Facebook.